John Z. Ayanian, MD, MPP (Harvard University); Professor of Health Policy and anagement; Professor of Medicine and Health Care Policy, Harvard Medical School. Access to care; quality of care; cardiovascular disease; cancer; primary and specialty are; health care disparities.
David W. Bates, MD (Johns Hopkins Medical School), SM (Harvard University); Professor of Medicine and Health Care Policy. Safety, quality, informatics, improving safety and quality using information technology, primary care.
Maureen Bisognano, MS (Boston University); Instructor in Health Policy and Management, HSPH; Executive Vice President and COO, Institute for Healthcare Improvement. Quality improvement in health care; strategic planning; leadership.
K. Arnold Chan, MD (National Taiwan University), SD (Harvard University); Adjunct Associate Professor of Epidemiology. Pharmacoepidemiology; drug safety assessment; drug utilization; therapeutic risk management.
Roger B. Davis, MA (University of Rochester), SD (Harvard University); Associate Professor in the Department of Biostatistics, HSPH; Associate Professor of Medicine, Harvard Medical School. Design and analysis of clinical trials; recursive partitioning methods; collaboration with medical investigators; health services research.
Jonathan Einbinder, MD (Columbia University), MPH (Harvard University); Corporate Manager for Quality Data Management, Partners HealthCare System; practicing general internist at Brigham and Women's Hospital. Measuring and improving quality using information systems, with a particular focus on data warehousing, population registries, and clinical dashboards.
Arnold M. Epstein, MA (Harvard University), MD (Duke University); John H. Foster Professor and Chair, Department of Health Policy and Management, HSPH; Professor of Medicine, Harvard Medical School. Quality of care and disparities in care for disadvantaged populations.
Paul Farmer, MD, PhD (Harvard University); Presley Professor, Harvard Medical School; Associate Chief, Division of Global Health Equity, Brigham and Women's Hospital; co-founder, Partners In Health; co-founder, Global Health Delivery Project. Health and human rights; treatment of HIV/AIDS and tuberculosis (including MDRTB) in resource-poor settings; the role of social inequalities in determining the distribution and outcomes of infectious diseases.
Garrett M. Fitzmaurice, SD (Harvard University); Professor in the Department of Biostatistics, HSPH; Professor of Psychiatry, Harvard Medical School. Design and analysis of longitudinal and repeated measures studies; missing-data methods; collaboration with medical investigators.
Richard D. Gelber, MS (Stanford University), PhD (Cornell University); Professor of Pediatrics (Biostatistics), Harvard Medical School. Design and analysis of clinical trials; quality-of-life endpoints for clinical trials; statistical education of medical professionals.
Rose Goldman, MD (Yale University), MPH (Harvard University); Associate Professor in the Department of Environmental Health, HSPH; Associate Professor of Medicine, Harvard Medical School; co-project director, the New England Pediatric Environmental Health Specialty Unit at Cambridge Hospital and Children's Hospital Boston. Repetitive strain injuries; neurotoxicity; metals; pediatric environmental health; teaching of environmental and occupational medicine.
Jennifer Haas, MD, SM (Harvard University); Associate Professor of Society, Human Development, and Health, HSPH; Associate Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School. Social and behavioral determinants of access to care and health outcomes.
Brian C. Healy, PhD (Harvard University); Instructor of Neurology, Harvard Medical School; Biostatistician, Partners Multiple Sclerosis (MS) Center. Modeling progression of the clinical course of the MS.
Albert Hofman, MD (University of Groningen), PhD (Erasmus University); Adjunct Professor, Department of Epidemiology, HSPH. Incidence and risk factors of Alzheimer's disease, vascular dementia, Parkinson's disease and Creutzfeld-Jakob disease. Determinants of atherosclerosis, heart disease, and stroke.
M. G. Myriam Hunink, MD (University of Leiden), PhD (Erasmus University); Professor of Clinical Epidemiology and Radiology, Erasmus University Medical Center; Adjunct Professor of Health Policy, HSPH. Assessment of diagnostic imaging and image-guided therapeutic technologies, using techniques from clinical epidemiology, meta-analysis, decision modeling, and cost-effectiveness analysis.
Ichiro Kawachi, MD, PhD (University of Otago), DipCommH (College of Community Medicine of New Zealand); Professor of Social Epidemiology and Chair, Department of Society, Human Development, and Health, HSPH. Health disparities, especially related to income distribution; stress and cardiovascular disease; healthy aging; tobacco control.
Molly Kile, SM, SD (Harvard University); Research Fellow in the Department of Environmental Health, HSPH. Exposure assessment; environmental epidemiology; risk assessment; focus on metals and issues related to drinking-water quality.
Jim Kim, MD, PhD (Harvard University). François Xavier Bagnoud Professor of Health and Human Rights, Harvard School of Public Health; Professor of Medicine and Social Medicine, Harvard Medical School; Chief, Division of Global Health Equity, Brigham & Women's Hospital; Director, François Xavier Bagnoud Center for Health and Human Rights; co-founder, Partners In Health; and co-founder, Global Health Delivery Project. Treatment of HIV/AIDS and tuberculosis (including MDRTB) in resource-limited settings; effects of economic and political change on health outcomes in developing countries; and the impact of Global Health Initiatives (GHIs) on health systems strengthening.
Anthony L. Komaroff, MD (University of Washington); Simcox-Clifford-Higby Professor of Medicine, Harvard Medical School.Clinical epidemiologic studies of common problems in primary care; computer systems in medical care; publishing of medical information for the public.
Francine Laden, SD (Harvard University); Assistant Professor of Environmental Epidemiology, HSPH; Assistant Professor of Medicine (Epidemiology), Harvard Medical School. Epidemiologic studies of environmental risk factors, including exposure to air pollution and persistent organic pollutants; risk of cancer, mortality, and chronic respiratory and cardiovascular disease.
Ellen P. McCarthy, PhD (Tulane University), MPH (Tulane University); Assistant Professor of Medicine, Harvard Medical School. Health services research; decision making in cancer and end-of-life care; health care disparities; public-use databases.
Michelle Mello, MPhil (Oxford University), PhD (University of North Carolina), JD (Yale University); Professor of Law and Public Health. Public health law and ethics; research ethics; medical malpractice; medical errors and patient safety; mass tort litigation.
Blackford Middleton, MD (SUNY-Buffalo), MPH (Yale University), MSc (Stanford University); Corporate Director, Clinical Informatics Research & Development; Chair, Center for IT Leadership, Partners HealthCare System. Design and implementation of integrated clinical information systems; special focus on electronic health records, clinical decision support, technology assessment, and patient-centered informatics.
Murray A. Mittleman, MD, CM (McGill University), MPH, DPH (Harvard University); Associate Professor in the Department of Epidemiology, HSPH; Associate Professor of Medicine, Harvard Medical School. Epidemiologic methods; cardiovascular epidemiology; stress and heart disease; injury epidemiology.
Joseph Rhatigan, MD (Harvard University); Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Division of Global Health Equity, Brigham and Women's Hospital; Director, Doris and Howard Hiatt Residency in Global Health Equity, Brigham and Women's Hospital; Faculty Member, Global Health Delivery Project. Graduate medical education in global health; health care service delivery in resource-poor settings.
Marc J. Roberts, PhD (Harvard University); Professor of Political Economy. Health policy; environmental policy; ethical aspects of allocating scarce public health resources; health sector reform in Asia and the Middle East.
Meredith Rosenthal, PhD (Harvard University); Associate Professor of Health Economics and Policy. Health economics; U.S. health policy; payment incentives; consumer-directed health plans; pharmaceutical industry.
Donald C. Simonson, MD (Yale University), MBA (MIT), MPH, SD (Harvard University); Lecturer on Medicine, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School. Clinical pathophysiology and treatment of diabetes and related metabolic disorders; health outcomes research; disease management; health economics.
Kenneth E. Stanley, MA (Bucknell University), PhD (University of Florida); Lecturer on Biostatistics, HSPH. Clinical trials; clinical and natural history research in HIV disease; estimating mortality attributable to tobacco in the presence of incomplete information.
Michael Stoto, PhD (Harvard University); Adjunct Professor of Biostatistics, HSPH; Director, Evaluation Core, Center for Public Health Preparedness, HSPH; and Professor of Health Services Administration and Population Health, Georgetown University School of Nursing & Health Studies. Methodological topics in research synthesis/meta-analysis, community health assessment, and performance measurements; substantive topics in public health practice, especially emergency preparedness.
David Studdert, LLB (University of Melbourne), MPH, SD (Harvard University); Federation Fellow and Professor, University of Melbourne. Health law and regulation; medical malpractice, medical injuries, and quality of care; dispute resolution; medical ethics.
Marcia A.Testa, MPH, MPhil, PhD (Yale University); Senior Lecturer on Biostatistics, HSPH. Applied areas of research: evaluating quality-of-life and health economic outcomes in therapeutic clinical trials and quality-of-care research, and quantifying and evaluating public health preparedness in relation to bioterrorism, counterterrorism, emerging infections and natural disasters; methodological research: measurement of latent constructs, structural equation modeling, analysis of multiple endpoints, and large database analytical algorithms.